3 Biotechs Seeking $271M IPO in the New Year Post author:Sam Post published:January 1, 2018 Post category:BioPharma Three biotech companies want to start out the new year with a new start. Source: BioSpace You Might Also Like Former Google Exec Steps Down as GRAIL CEO August 2, 2017 Seegene Enters The U.S. Diagnostic Market In Collaboration With Thermo Fisher Scientific May 22, 2017 <b>Vividion Therapeutics</b> Launches With $50 Million and a Celgene Alum as Executive Chairman February 1, 2017
Seegene Enters The U.S. Diagnostic Market In Collaboration With Thermo Fisher Scientific May 22, 2017
<b>Vividion Therapeutics</b> Launches With $50 Million and a Celgene Alum as Executive Chairman February 1, 2017
